Molecules called reactive oxygen species, which include so-called "free radicals," have long been viewed as damaging byproducts of our body's metabolism—a reason antioxidant supplements have been considered a potential way ...
Sep 3, 2026
0
135
Balancing work and personal life is more challenging for evening types, or "night owls," than for morning types, or "early birds." Evening types have a harder time recovering from work and are more likely to have mental health ...
Aug 31, 2026
0
127
The investigational anti-interleukin-6 (IL-6) monoclonal antibody pacibekitug produced sustained reductions in inflammation-related biomarkers through six months in patients with chronic kidney disease and elevated inflammatory ...
Aug 29, 2026
0
96
National Institutes of Health (NIH) researchers have discovered rare antibodies that could inform the development of an intervention for alpha-gal syndrome (AGS), an emerging tick bite-associated condition that can cause ...
Sep 1, 2026
0
81
Rice University and collaborators in Switzerland have developed a platform to grow human-derived nerve cells and Schwann cells, supporting cells that form a protective coating called myelin around nerve fibers. This platform ...
Aug 31, 2026
0
64
Men diagnosed with nonmetastatic prostate cancer can generally expect to live for many years after their diagnosis. However, cardiovascular disease and other cancers remain important threats to their long-term health. For ...
Sep 2, 2026
0
62
High-fructose corn syrup is just one of many food additives linked to obesity. It is typically found in sweetened beverages and processed foods and is added to enhance flavor and sweetness. However, exactly how it contributes ...
A new study published in Nature Aging on Aug. 25 reports that a single gut bacterium—Bifidobacterium pseudocatenulatum (BP)—together with a small molecule it produces, 5-aminovaleric acid betaine (5-AVAB), can alleviate multiple ...
Sep 1, 2026
0
61
A new phase 1 clinical trial has found that an emerging immunotherapy is promising for treating recurrent glioblastoma, a highly aggressive and fatal brain cancer. Chimeric antigen receptor T (CAR-T) cell therapy is a form ...
Aug 31, 2026
0
48
In a breakthrough study, researchers at The University of Texas MD Anderson Cancer Center discovered that psilocybin given before chemotherapy prevented the onset of nerve injury in preclinical models, even after repeated ...
Sep 3, 2026
0
47
